Literature DB >> 6736249

Pyruvate kinase and the "high ATP syndrome".

G E Staal, G Jansen, D Roos.   

Abstract

The erythrocytes of a patient with the so-called "high ATP syndrome" were characterized by a high ATP content and low 2,3-diphosphoglycerate level. The pyruvate kinase activity was specifically increased (about twice the normal level). After separation of the erythrocytes according to age by discontinuous Percoll density centrifugation, the pyruvate kinase activity was found to be increased in all Percoll fractions. Pyruvate kinase of the patient's cells was characterized by a decreased K0.5 for the substrate phosphoenolpyruvate and no inhibition by ATP. The Michaelis constant (Km) value for ADP, the nucleotide specificity, the thermostability, pH optimum, and immunological specific activity were normal. It is concluded that the high pyruvate kinase activity is due to a shift in the R(elaxed) in equilibrium T(ight) equilibrium to the R(elaxed) form.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6736249      PMCID: PMC425205          DOI: 10.1172/JCI111406

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

Review 1.  Interrelationships and functions of the pyruvate kinase isozymes and their variant forms: a review.

Authors:  K H Ibsen
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

2.  The removal of leukocytes and platelets from whole blood.

Authors:  E Beutler; C West; K G Blume
Journal:  J Lab Clin Med       Date:  1976-08

3.  Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency.

Authors:  D Roos; R S Weening; A A Voetman; M L van Schaik; A A Bot; L J Meerhof; J A Loos
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

4.  Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes.

Authors:  S Minakami; C Suzuki; T Saito; H Yoshikawa
Journal:  J Biochem       Date:  1965-12       Impact factor: 3.387

5.  Human erythrocyte pyruvate kinase. Its purification and some properties.

Authors:  G E Staal; J F Koster; H Kamp; L van Milligen-Boersma; C Veeger
Journal:  Biochim Biophys Acta       Date:  1971-01-13

6.  Determination of O-methylated metabolites of cathecholamines using high-performance liquid chromatography and electrochemical detection.

Authors:  R T Borchardt; M F Hegazi; R L Schowen
Journal:  J Chromatogr       Date:  1978-05-11

7.  Enzyme activities related to 2,3-P2-glycerate metabolism in embryonic and fetal red cells.

Authors:  W Jelkmann; C Bauer
Journal:  Biochem Biophys Res Commun       Date:  1980-03-13       Impact factor: 3.575

8.  Human erythrocyte fraction in "Percoll" density gradients.

Authors:  C M Rennie; S Thompson; A C Parker; A Maddy
Journal:  Clin Chim Acta       Date:  1979-10-15       Impact factor: 3.786

9.  The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver.

Authors:  A Kahn; J Marie; H Garreau; E D Sprengers
Journal:  Biochim Biophys Acta       Date:  1978-03-14

10.  Pyruvate kinase hyperactivity genetically determined metabolic consequences and molecular characterization.

Authors:  I Max-Audit; R Rosa; J Marie
Journal:  Blood       Date:  1980-11       Impact factor: 22.113

View more
  2 in total

1.  Senescent erythrocytes: isolation of in vivo aged cells and their biochemical characteristics.

Authors:  T Suzuki; G L Dale
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

2.  Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis.

Authors:  Helen R Gosselt; Ittai B Muller; Gerrit Jansen; Michel van Weeghel; Frédéric M Vaz; Johanna M W Hazes; Sandra G Heil; Robert de Jonge
Journal:  J Pers Med       Date:  2020-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.